Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients. [electronic resource]
- Investigative urology Mar 1980
- 386-9 p. digital
Publication Type: Journal Article
0021-0005
Adult Aged Biological Products--therapeutic use Doxorubicin--therapeutic use Female Humans Lymphocyte Activation--drug effects Male Middle Aged Picibanil--therapeutic use Receptors, Fc--immunology T-Lymphocytes--immunology Urinary Bladder Neoplasms--therapy Urogenital Neoplasms--therapy